Esperion





Nice to see the home office lackey also being tge grammar police and the hall monitor all at once. No clinical discussion as per usual. Stock still being flaccid in the $6.00 range. Impressive.
 








Exactly the response that have always come from the Scientifically Hired, Highly Tenured Customer Facing Team.
When you ask for a Clinical discussion --- the answer is name calling
When you ask about the stock price ----the answer is name calling
When you ask about success of BA----the answer is name calling

We can go on, but you know what their response will be ----more name calling.

Shallow company and organizations react this way.
 




Exactly the response that have always come from the Scientifically Hired, Highly Tenured Customer Facing Team.
When you ask for a Clinical discussion --- the answer is name calling
When you ask about the stock price ----the answer is name calling
When you ask about success of BA----the answer is name calling

We can go on, but you know what their response will be ----more name calling.

Shallow company and organizations react this way.
Group of pathetic stalking losers
 




Yes the insults will continue from the home office if you as a clinically revalenet question. No culture at Esperion to speak off.Wasn't Esperion supposed to be the poster for The Scientific Hiring Process. Lots of bragging went on in 2020 when posters were claiming that this hiring process spearheaded by Esperion was sweeping the pharma industry. Sorry to say that this didn't happen just like how primary care was going going to be the driver of BA. Sadly it all ended up being a mess and debacle. How much longer ??
 




Yes the insults will continue from the home office if you as a clinically revalenet question. No culture at Esperion to speak off.Wasn't Esperion supposed to be the poster for The Scientific Hiring Process. Lots of bragging went on in 2020 when posters were claiming that this hiring process spearheaded by Esperion was sweeping the pharma industry. Sorry to say that this didn't happen just like how primary care was going going to be the driver of BA. Sadly it all ended up being a mess and debacle. How much longer ??

Huh?, clearly no semi- intelligent human being would say this. If this is how you communicated in the interview that’s it’s no surprise you weren’t hired.
 




Huh?, clearly no semi- intelligent human being would say this. If this is how you communicated in the interview that’s it’s no surprise you weren’t hired.

Wow

This person believes and defends the Scientific Hiring Process.
Much like the Gov't response to Covid...They will never mention they were wrong.
Narcissim abounds.
 




















It’s a pretty good outfit in a pretty good gig overall, product has great potential going forward. The outcomes data Should provide the opportunity to re-launch; The uptake thus far has been greatly attenuated by Covid, And as the restrictions lift the prescriptions soar.
 




It’s a pretty good outfit in a pretty good gig overall, product has great potential going forward. The outcomes data Should provide the opportunity to re-launch; The uptake thus far has been greatly attenuated by Covid, And as the restrictions lift the prescriptions soar.

so, the trend of top reps leaving doesn’t bother you lackey?
 








More excuses from Esperion. Funny how other good companies adjusted to covid. Pharma launches during covid show Esperions BA and the bottom of the heap. This had more to do with incompetence of management and poorly assembled reps. Give it a rest about covid. Nobody buys that excuse except the horrific management team.
 








Attitude will always outdo altitude, this is no exception. We like the position we are in, We are confident as we move forward; the future is bright and we can see the light, look out ahead as we punch our ticket forward for the millions of patients that NEED US.
 




Yep everyone! Bend over and grab your ankles if your an Esperion investor. The altitude of BS is at an all time high. Dud,dud,dud!! This drug is officially a dud along with the management team.